160 likes | 256 Views
Proteomic Characterization of Alternative Splicing and Coding Polymorphism. Nathan Edwards Center for Bioinformatics and Computational Biology University of Maryland, College Park. Why don’t we see more novel peptides?.
E N D
Proteomic Characterization of Alternative Splicing and Coding Polymorphism Nathan Edwards Center for Bioinformatics and Computational Biology University of Maryland, College Park
Why don’t we see more novel peptides? • Tandem mass spectrometry doesn’t discriminate against novel peptides......but protein sequence databases do! • Searching traditional protein sequence databases biases the results towards well-understood protein isoforms!
What goes missing? • Known coding SNPs • Novel coding mutations • Alternative splicing isoforms • Alternative translation start-sites • Microexons • Alternative translation frames
Why should we care? • Alternative splicing is the norm! • Only 20-25K human genes • Each gene makes many proteins • Proteins have clinical implications • Biomarker discovery • Evidence for SNPs and alternative splicing stops with transcription • Genomic assays, ESTs, mRNA sequence. • Little hard evidence for translation start site
Novel Splice Isoform • Human Jurkat leukemia cell-line • Lipid-raft extraction protocol, targeting T cells • von Haller, et al. MCP 2003. • LIME1 gene: • LCK interacting transmembrane adaptor 1 • LCK gene: • Leukocyte-specific protein tyrosine kinase • Proto-oncogene • Chromosomal aberration involving LCK in leukemias. • Multiple significant peptide identifications
Novel Mutation • HUPO Plasma Proteome Project • Pooled samples from 10 male & 10 female healthy Chinese subjects • Plasma/EDTA sample protocol • Li, et al. Proteomics 2005. (Lab 29) • TTR gene • Transthyretin (pre-albumin) • Defects in TTR are a cause of amyloidosis. • Familial amyloidotic polyneuropathy • late-onset, dominant inheritance
Novel Mutation Ala2→Pro associated with familial amyloid polyneuropathy
Pros No introns! Primary splicing evidence for annotation pipelines Evidence for dbSNP Often derived from clinical cancer samples Cons No frame Large (8Gb) “Untrusted” by annotation pipelines Highly redundant Nucleotide error rate ~ 1% Searching Expressed Sequence Tags (ESTs)
Compressed EST Peptide Sequence Database • For all ESTs mapped to a UniGene gene: • Six-frame translation • Eliminate ORFs < 30 amino-acids • Eliminate amino-acid 30-mers observed once • Compress to C2 FASTA database • Complete, Correct for amino-acid 30-mers • Gene-centric peptide sequence database: • Size: 223 Mb vs 8 Gb, 20774 FASTA entries • Running time: 15 mins vs 22 hours • E-values: 50-fold reduction • Download: • http://www.umiacs.umd.edu/~nedwards
Back to the lab... • Current LC/MS/MS workflows identify a few peptides per protein • ...not sufficient for protein isoforms • Need to raise the sequence coverage to (say) 80% • ...protein separation prior to LC/MS/MS analysis
Future informatics directions... • Combine results from multiple searches from multiple engines • Fast, automated triage of “significant false-positive” peptide identifications • Compressed EST peptide sequence database for other species • Mouse, Rat, Zebrafish, Chicken, Cow, A. thaliana, ?? • Relational database and web-application infrastructure • Interactive browser data-grid, flexible web-services export • Java Applet MS/MS viewers, GFF for Genome Browser
Conclusions • Peptides identify more than just proteins • Untapped source of disease biomarkers • Functional vs silencing variants • Compressed peptide sequence databases make routine EST searching feasible • Statistically significant peptide identification is only the first step
Acknowledgements • Catherine Fenselau, Steve Swatkoski • UMCP Biochemistry • Chau-Wen Tseng, Xue Wu • UMCP Computer Science • Cheng Lee • Calibrant Biosystems • PeptideAtlas, HUPO PPP, X!Tandem • Funding: NCI